Bifocals May Slow Progression of Myopia in Children
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Bifocals May Slow Progression of Myopia in Children

CHICAGO -- January 11, 2010 -- Bifocal glasses may be effective in slowing the progression of myopia in children with high rates of progression, according to a study published in the January issue of Archives of Ophthalmology.

Desmond Cheng, OD, then of the Queensland University of Technology, Brisbaine, Australia, and now with Hong Kong Polytechnic University, Hong Kong, China, and colleagues conducted a randomised controlled clinical trial among 135 Chinese Canadian children (mean age, 10.3 years) in 1 practice with progressing myopia.

Children were assigned to 1 of 3 treatment groups: 41 wore single-vision lenses, 48 wore bifocals, and 46 wore bifocals with prism.

Of the 135 children, 131 completed the 24-month study. Progression of myopia was most rapid among those who wore single-focus lenses, slower among those who wore bifocals, and slowest among those who wore prismatic bifocals.

Because the fundamental characteristics of myopia likely do not vary by ethnic group, the results would likely apply to other children with rapidly progressing forms of the condition, the authors noted.

“The proportion of myopic children in this practice with fast myopic progression, therefore qualifying for bifocal treatment, was estimated to be about 54%,” the authors wrote. “Therefore, the bifocal treatment could benefit a large number of myopic children.”

“To date, there has been no consensus on what magnitude of myopic reduction constitutes a clinically significant control effect,” they concluded. “In our opinion, the treatment effect of bifocal and prismatic bifocal lenses of 38% and 55%, respectively, in this study, though greater than those of others, is still modest. Whether or not the effect tapers off will decide clinical significance. If the treatment effects continued over time, then the treatment could have a significant role in preventing the development of very high pathologic myopia.” Therefore, long-term studies are needed, they noted.

SOURCE: Archives of Ophthalmology

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities